Division of Dermatology, Department of Medicine, University of Toronto School of Medicine, Toronto, Canada.
Mediprobe Research Inc, London, Canada.
J Dermatolog Treat. 2023 Dec;34(1):2245084. doi: 10.1080/09546634.2023.2245084.
Mesotherapy is a technique by which lower doses of therapeutic agents and bioactive substances are administered by intradermal injections to the skin. Through intradermal injections, mesotherapy can increase the residence time of therapeutic agents in the affected area, thus allowing for the use of lower doses and longer intervals between sessions which may in turn improve the treatment outcome and patient compliance. This systematic review aims to summarize the current literature that evaluates the efficacy of this technique for the treatment of hair loss and provides an overview of the results observed. Of the 416 records identified, 27 articles met the inclusion criteria. To date, mesotherapy using 6 classes of agents and their combinations have been studied; this includes dutasteride, minoxidil, growth factors or autologous suspension, botulinum toxin A, stem cells, and mesh solutions/multivitamins. While several studies report statistically significant improvements in hair growth after treatment, there is currently a lack of standardized regimens. The emergence of adverse effects after mesotherapy has been reported. Further large-scale and controlled clinical trials are warranted to evaluate the utility of mesotherapy for hair loss disorders.
中胚层疗法是一种通过皮内注射将较低剂量的治疗剂和生物活性物质递送至皮肤的技术。通过皮内注射,中胚层疗法可以增加治疗剂在受影响区域的停留时间,从而允许使用较低的剂量和更长的治疗间隔,这反过来又可以改善治疗效果和患者的依从性。本系统评价旨在总结目前评估该技术治疗脱发疗效的文献,并概述观察到的结果。在确定的 416 条记录中,有 27 篇文章符合纳入标准。迄今为止,已经研究了使用 6 类药物及其组合的中胚层疗法;这包括度他雄胺、米诺地尔、生长因子或自体悬浮液、肉毒杆菌毒素 A、干细胞和网孔溶液/多种维生素。虽然几项研究报告治疗后毛发再生有统计学意义的改善,但目前缺乏标准化方案。中胚层疗法后出现不良反应的报道。需要进一步的大规模对照临床试验来评估中胚层疗法治疗脱发障碍的效用。